Balchem Corp
BCPC
Classement en actions
#3246
Balchem Corporation develops, manufactures, and distributes specialty... Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Prix de l'action
$171.40
Capitalisation boursière
$5.46B
Changement (1 jour)
0.57%
Changement (1 an)
13.68%
Pays
US
Échange Balchem Corp (BCPC)
Catégorie
Basic Materials
Ratio P/E pour Balchem Corp (BCPC)
Ratio P/E au October 2026 TTM : 33.29
Selon les derniers rapports financiers et le cours de l'action de Balchem Corp, le ratio P/E actuel (TTM) est de 33.29. À la fin de l’année 2023, le P/E de l’entreprise était de 44.00.
Historique du ratio P/E pour Balchem Corp de 2000 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 33.29 | -18.84% |
| 2024 | 41.02 | -6.77% |
| 2023 | 44.00 | 18.58% |
| 2022 | 37.11 | -34.34% |
| 2021 | 56.52 | 29.00% |
| 2020 | 43.81 | 6.87% |
| 2019 | 40.99 | 27.45% |
| 2018 | 32.16 | 12.26% |
| 2017 | 28.65 | -39.82% |
| 2016 | 47.62 | 50.11% |
| 2015 | 31.72 | -18.48% |
| 2014 | 38.91 | 0.41% |
| 2013 | 38.75 | 44.40% |
| 2012 | 26.84 | -10.19% |
| 2011 | 29.88 | 5.18% |
| 2010 | 28.41 | 17.98% |
| 2009 | 24.08 | 2.48% |
| 2008 | 23.50 | -4.45% |
| 2007 | 24.59 | 0.59% |
| 2006 | 24.45 | 16.30% |
| 2005 | 21.02 | -3.15% |
| 2004 | 21.71 | 11.49% |
| 2003 | 19.47 | 25.00% |
| 2002 | 15.58 | -19.80% |
| 2001 | 19.42 | 17.14% |
| 2000 | 16.58 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 31.66 | -4.89% |
GB
|
|
| - | - |
FR
|
|
| 29.64 | -10.98% |
US
|
|
| 38.37 | 15.26% |
US
|
|
| -1.41K | -4,324.29% |
US
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.